PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of ccforumBioMed CentralBiomed Central Web Sitesearchsubmit a manuscriptregisterthis articleCritical CareJournal Front Page
 
Crit Care. 2010; 14(Suppl 1): P162.
Published online 2010 March 1. doi:  10.1186/cc8394
PMCID: PMC2934170

Metformin increases platelet lactate production by inhibiting mitochondrial function

Introduction

Metformin improves glucose control by inhibiting hepatocyte mitochondrial complex I [1]. The pathogenesis of metforminassociated lactic acidosis is poorly understood and whether drug accumulation per se can cause hyperlactatemia remains unclear. The aim of the present study is to clarify whether metformin can increase cellular lactate production by inhibiting mitochondrial function in tissues other than the liver.

Methods

Platelet-rich-plasma (PRP) from healthy volunteers was incubated for 72 hours with different doses of metformin. The plasma lactate concentration was then measured. The proportion of normally polarized vs abnormally depolarized platelet mitochondria (FL2/FL1) was assessed by flow cytometry after staining with JC-1. Platelet respiratory chain complex I activity and citrate synthase (CS) activity, a marker of mitochondrial content, were measured by spectrophotometry. Data are presented as means ± SD. Analysis was performed with one-way ANOVA.

Results

Main results are reported in Table Table11.

Conclusions

Metformin can cause hyperlactatemia by impairing platelet mitochondrial function.

References

  • El-Mir MY, Nogueira V, Fontaine E, Avéret N, Rigoulet M, Leverve X. J Biol Chem. 2000. pp. 223–228. [PubMed] [Cross Ref]

Articles from Critical Care are provided here courtesy of BioMed Central